The benefit of GLP-1 RAs exceeded the harms for weight loss in the first 2 years of treatment, yet the net benefit was dependent on individual treatment goals (10% or 5% weight loss) and willingness to accept harms in pursuit of weight loss
use proper technique
Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
The only mention is not associated with Eli Lilly or Novo Nordisk, which doesnt clarify whats being provided
Limit high-sulfur foods to one serving (about 34 oz) per day, and prioritize lean, low-sulfur proteins (like chicken, turkey, white fish) and low-sulfur veggies (like zucchini, lettuce, cucumbers, bell peppers) the rest of the time
Intensive Lifestyle Intervention: Another study showed an additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention alongside tirzepatide